Literature DB >> 3709822

Clinical evaluation of axillar lymph nodes compared to surgical and pathological findings.

R A Sacre.   

Abstract

Reviewing the axillar lymph node status in 196 consecutive breast cancer patients and comparing clinical assessment to pathological findings, the author found an overall erroneous appraisal of 39% with 45% false negative and 29% false positive cases. In more than 15% of the cases there were skip metastases. In the T1 group, stratification to the greatest diameter of the tumor gave a significant difference (P less than 0.01) between axillar LNI in tumours smaller or equal to 1 cm and those with a diameter between 1 and 2 cm. Lymph node metastases in the interpectoral space is extremely rare (less than 0.5%) and always macroscopic. Axillar lymph nodes were always invaded in T4 tumours. The author warns against clinical studies based upon clinical assessment of the axillar lymph node status. He advocates a complete axillar lymph node dissection in all cases. He suggests that the T1 classification should be restricted to tumours with a diameter smaller or equal to 1 cm.

Entities:  

Mesh:

Year:  1986        PMID: 3709822

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  19 in total

Review 1.  Axillary staging of breast cancer and the sentinel node.

Authors:  G Cserni
Journal:  J Clin Pathol       Date:  2000-10       Impact factor: 3.411

2.  Contrast-Enhanced Color Doppler Ultrasonography for Preoperative Evaluation of Sentinel Lymph Node in Breast Cancer Patients.

Authors:  Dionysios Dellaportas; Andreas Koureas; John Contis; Panagis M Lykoudis; Irene Vraka; Dimitrios Psychogios; Agatha Kondi-Pafiti; Dionysios K Voros
Journal:  Breast Care (Basel)       Date:  2015-07-10       Impact factor: 2.860

3.  Prognostic value of the interpectoral lymph nodes in breast cancer. A 20-year survival study.

Authors:  A García-Vilanova Comas; A García Vilanova; E Fuster-Diana; N Martínez-Alzamora; Jm Fernández-Tena; J García-Vilanova Comas; M García-Vilanova Comas
Journal:  Clin Transl Oncol       Date:  2006-02       Impact factor: 3.405

Review 4.  Radiomics MRI for lymph node status prediction in breast cancer patients: the state of art.

Authors:  Alessandro Calabrese; Domiziana Santucci; Roberta Landi; Bruno Beomonte Zobel; Eliodoro Faiella; Carlo de Felice
Journal:  J Cancer Res Clin Oncol       Date:  2021-03-23       Impact factor: 4.553

5.  Clinical behavior of untreated axillary nodes after local treatment for primary breast cancer.

Authors:  N Baxter; D McCready; J A Chapman; E Fish; H Kahn; W Hanna; M Trudeau; H L Lickley
Journal:  Ann Surg Oncol       Date:  1996-05       Impact factor: 5.344

Review 6.  Diagnosis of axillary lymph node metastases in patients with breast cancer.

Authors:  M Noguchi; N Katev; I Miyazaki
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

7.  [Sentinel lymph node biopsy in breast cancer].

Authors:  Gero Luschin
Journal:  Wien Med Wochenschr       Date:  2010-10-12

8.  Classification of Metastatic versus Non-Metastatic Axillary Nodes in Breast Cancer Patients: Value of Cortex-Hilum Area Ratio with Ultrasound.

Authors:  Sung Eun Song; Bo Kyoung Seo; Seung Hwa Lee; Ann Yie; Ki Yeol Lee; Kyu Ran Cho; Ok Hee Woo; Sang Hoon Cha; Baek Hyun Kim
Journal:  J Breast Cancer       Date:  2012-03-28       Impact factor: 3.588

9.  Feasibility of fine-needle aspiration for assessing responses to chemotherapy in metastatic nodes marked with clips in breast cancer: A prospective registry study.

Authors:  Abigail S Caudle; Henry M Kuerer; Savitri Krishnamurthy; Kyungmin Shin; Brian P Hobbs; Junsheng Ma; Elizabeth A Mittendorf; Ashley C Washington; Sarah M DeSnyder; Dalliah M Black; Kelly K Hunt; Wei T Yang
Journal:  Cancer       Date:  2018-10-25       Impact factor: 6.860

10.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer.

Authors:  A E Giuliano; D M Kirgan; J M Guenther; D L Morton
Journal:  Ann Surg       Date:  1994-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.